Blog

Amr M.Elhadidy: I Have Successfully Passed the ESMO examination 2024

Amr M.Elhadidy/researchgate.net

Nov 26, 2024, 16:48

Amr M.Elhadidy: I Have Successfully Passed the ESMO examination 2024

Amr M.Elhadidy, Clinical Oncology Specialist at Al Azhar University, shared a post on LinkedIn:

“I have successfully passed The ESMO examination 2024.”

Al-Azhar University Amr M.Elhadidy cancer clinical oncology ESMO European Society for Medical Oncology OncoDaily Oncology

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

RSS Feed

Youtube

Blog

Feb 22, 2025, 04:54

Rick Dean is stepping down as the CEO of OncoHealth

Blog

Feb 22, 2025, 04:49

Wafaa Rashed: Advancing Ethical and Evidence-Based Policy in Genomics

Blog

Feb 22, 2025, 04:42

Jessica Schubel: I'm launching my very own health care and aging policy consulting firm - Day One Strategies

Blog

Feb 22, 2025, 04:37

Karen Knudsen: Honored to be part of the Moffitt Cancer Center External Advisory Committee

Blog

Feb 22, 2025, 04:33

SPCC announced the upcoming launch of the "Digital Oncology" book series

Blog

Feb 22, 2025, 04:29

Results from the SIOPE OCEAN project are out

Blog

Feb 22, 2025, 04:25

Empower families to face their cancer journey with strength and hope - Cancer Hope Network

Blog

Feb 22, 2025, 04:19

Secure your spot for the CCI4EU Online Course by ESO

Blog

Feb 22, 2025, 04:16

Manchester Cancer Research Centre will continue its leadership in early detection science following the renewal of ACED

Blog

Feb 22, 2025, 04:12

Citrus Oncology is part of the 14 startups selected for the 2025 CancerX Accelerator

Science

Feb 22, 2025, 04:08

Anticancer potential of NO-Donor Oxadiazole in malignant pleural mesothelioma - The Babak Lab

Blog

Feb 22, 2025, 03:56

Early bird registration deadline for the 15th CCI Europe Conference approaches